Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 138,103 | 101,214 | 53,163 | 37,312 | 100,362 |
| Gross Profit | 138,103 | 101,214 | 53,163 | 37,312 | 100,362 |
| Operating Expenses | 113,108 | 107,698 | 154,498 | 153,354 | 148,967 |
| Operating Income | 24,995 | -6,484 | -101,335 | -116,042 | -48,605 |
| Other Income | 7,098 | 9,807 | 2,018 | 172 | 1,809 |
| Pre-tax Income | 32,093 | 3,323 | -99,317 | -115,870 | -46,796 |
| Income Tax | 224 | 3,892 | N/A | N/A | -13,911 |
| Net Income Continuous | 31,869 | -569 | -99,317 | -115,870 | -32,885 |
| Net Income | $31,869 | $-569 | $-99,317 | $-115,870 | $-32,885 |
| EPS Basic Total Ops | 0.38 | -0.01 | -1.51 | -1.81 | -0.71 |
| EPS Basic Continuous Ops | 0.38 | -0.01 | -1.51 | -1.81 | -0.71 |
| EPS Diluted Total Ops | 0.38 | -0.01 | -1.51 | -1.81 | -0.71 |
| EPS Diluted Continuous Ops | 0.38 | -0.01 | -1.51 | -1.81 | -0.71 |
| EPS Diluted Before Non-Recurring Items | 0.38 | -0.01 | -1.51 | -1.30 | -0.71 |
| EBITDA(a) | $21,452 | $-11,728 | $-98,944 | $-113,064 | $-46,268 |